CRW
+0.0 · +0.00%
GBX · LSE

Craneware Plc(CRW) Stock Analysis | Healthcare

GBX --+0.00%
Reward70High
Risk27Low
75%Data
2.8% dividend yield
Defensive Anchor
Market Cap:476.58M
ⓘ
Reward Rating
70
High
Reward Assessment
75% data coverage
Top 25% of stocksView factors
ⓘ
Risk Rating
27
Low
Risk Assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on CRW to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Craneware Plc?

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States.

AI Brief Pro

The brief on Craneware Plc

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Craneware Plc?

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. It provides solutions, such as Trisus Pricing Analyzer and Transparency, a solution that optimizes and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity requirements; Trisus Claims Informatics, a retrospective charge capture analytical application; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit solution for government and commercial payors. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 476.58M, and a P/E ratio of 29.6x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: High (70)

Similar stocks to compare

A short list of Health Information Services names that are close enough in size to make side-by-side comparison useful.

All Healthcare stocks →
Company Information
IndustryHealth Information Services
Market Cap476.58M
P/E Ratio29.617
Beta-0.153
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.